Synthesis and Biological Activities of Arginine-Vasopressin Analogues with Reactive Groups
- 1 January 1980
- journal article
- research article
- Published by Walter de Gruyter GmbH in Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie
- Vol. 361 (1) , 153-168
- https://doi.org/10.1515/bchm2.1980.361.1.153
Abstract
The synthesis and biological activities of Arg-vasopressin [VP] analogs are described, where p-azido-L-phenylalanine [Phe(pN3)] or p-(bromoacetylamino)-L-phenylalanine [Phe-(pNHCOCH2Br)] replace Tyr2 or Phe3. The hormone analogs are prepared via precursors containing p-aminophenylalanine [Phe(pNH2)] in position 2 or 3. During peptide synthesis the p-amino group of [Phe(pNH2)] is protected by the tert-butyloxycarbonyl or the benzyloxycarbonyl group, the side chains of Cys and Arg by the acetamidomethyl residue and the tosyl group, respectively. The amino and guanidino protecting groups are removed from the nonapeptides by trifluoromethanesulfonic acid yielding the S-protected derivatives which are cyclized by means of I. The ring closure by disulfide formation is confirmed by Edman degradation, CD [circular dischroism] and 1H-NMR spectroscopy. Modifications at the p- and .alpha.-amino groups result in [Phe(pN3)2]-VP, [Phe(pNHCOCH2Br)2]VP, N.alpha.-dansyl-[Phe(pN3)2]VP, [Phe2,Phe(pN3)3]VP and [Phe2,Phe(pNHCOCH2Br)3]VP. The analogs modified only in position 2, [Phe(pN3)2]VP and [Phe(pNHCOCH2Br)2]VP stimulate the adenylate cyclase derived from bovine kidney inner medulla to similar maximal velocities as Arg VP and show high apparent affinites for enzyme activation. The N.alpha.-dansyl derivative and the analogs with reactive groups in position 3 have reduced maximal velocities and apparent affinities for VP-sensitive adenylate cyclase. The derivatives with reactive groups in position 2 are useful for the labeling of VP receptors in plasma membranes and for studies of covalent hormone-receptor complexes.This publication has 24 references indexed in Scilit:
- Selective Removal of the o‐Nitrophenylsulfenyl Protecting Group in Peptide SynthesisHelvetica Chimica Acta, 1978
- Totalsynthese von Humaninsulin. IV. Beschreibung der EndstufenHelvetica Chimica Acta, 1977
- Synthese von Humaninsulin. II. Aufbau des cyclischen Fragments A(1–13)Helvetica Chimica Acta, 1976
- Synthese von 4′‐Azido‐3′,5′‐ditritio‐L‐phenylalanin‐peptiden als « Photo‐affinitätsproben » für Ligand‐Rezeptor‐Wechselwirkungen. Vorläufige MitteilungHelvetica Chimica Acta, 1976
- Repetitive Excess Mixed Anhydride (REMA) Synthesis of Peptides. The protected C-terminal hexadecapeptide of secretinHelvetica Chimica Acta, 1973
- Zur Synthese von Peptiden mit Eigenschaften des Human‐Proinsulin‐C‐Peptids (hC‐Peptid), V. Darstellung der Sequenz 9–31 des Human‐Proinsulin‐C‐Peptids und seines [Glu9,Gln11]‐AnalogenEuropean Journal of Inorganic Chemistry, 1973
- Cystinpeptide aus (S‐Acetamidomethyl‐cystein)‐peptiden durch Oxydation mit Jod: Die synthese von cyclo‐L‐cystinHelvetica Chimica Acta, 1971
- Reinvestigation of the mixed carbonic anhydride method of peptide synthesisJournal of the American Chemical Society, 1967
- Studies on Polypeptides. XXXIV. Enzymic Properties of Partially Synthetic De(16-20)- and De(15-20)-ribonucleases S'1-3Journal of the American Chemical Society, 1966
- Selektive Spaltung substituierter Phenylsulfenyl‐Schutzgruppen bei PeptidsynthesenHelvetica Chimica Acta, 1966